The metastatic ability of ACTN4 in colorectal cancer [86], breast cancer [87], ovarian cancer [88], pancreatic cancer [89], salivary gland cancer [90], and prostate cancer [91] is related to the malignant phenotype. This evidence concerns the gene ACTN4 and familial pancreatic carcinoma.